{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:41:51Z","timestamp":1770748911171,"version":"3.50.0"},"reference-count":40,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2022,11,1]]},"abstract":"<jats:sec><jats:title>Importance<\/jats:title><jats:p>Mild thyroid-associated ophthalmopathy (TAO) negatively impacts quality of life, yet no clinical guidelines for its treatment are available. Existing evidence supports the use of doxycycline in treating mild TAO.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To evaluate the short-term (12 weeks) efficacy of doxycycline in treating mild TAO.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>In this placebo-controlled multicenter randomized double-masked trial, 148 patients were assessed for eligibility. After exclusions (patients who were pregnant or lactating, had an allergy to tetracyclines, or had uncontrolled systematic diseases), 100 patients with mild TAO (orbital soft tissue affected mildly) at 5 centers in China were enrolled from July 2013 to December 2019 and monitored for 12 weeks.<\/jats:p><\/jats:sec><jats:sec><jats:title>Interventions<\/jats:title><jats:p>Participants were randomly assigned 1:1 to receive doxycycline (50 mg) or placebo once daily for 12 weeks.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>The primary outcome was the rate of improvement at 12 weeks compared with baseline assessed by a composite indicator of eyelid aperture (reduction \u22652 mm), proptosis (reduction \u22652 mm), ocular motility (increase \u22658\u00b0), and Graves ophthalmopathy-specific quality-of-life (GO-QOL) scale score (increase \u22656 points). Adverse events were recorded.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 50 participants were assigned to doxycycline and 50 to placebo. The mean (SD) age was 36.7 (9.1) years; 75 participants (75.0%) were female and 100 (100.0%) were Asian. Medication compliance was checked during participant interviews and by counting excess tablets. At week 12, the improvement rate was 38.0% (19 of 50) in the doxycycline group and 16.0% (8 of 50) in the placebo group (difference, 22.0%; 95% CI, 5.0-39.0; <jats:italic>P<\/jats:italic>\u2009=\u2009.01) in the intention-to-treat population. The per-protocol sensitivity analysis showed similar results (39.6% [19 of 48] vs 16.0% [8 of 50]; difference, 23.6%; 95% CI, 6.4-40.8; <jats:italic>P<\/jats:italic>\u2009=\u2009.009). No adverse events other than 1 case of mild gastric acid regurgitation was recorded in either group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions and Relevance<\/jats:title><jats:p>The results of this study indicate that oral doxycycline, 50 mg daily, resulted in greater improvement of TAO-related symptoms at 12 weeks compared with placebo in patients with mild TAO. These findings support the consideration of doxycycline for mild TAO but should be tempered by recognizing the relatively short follow-up and the size of the cohort.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial Registration<\/jats:title><jats:p>ClinicalTrials.gov Identifier: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02203682\">NCT02203682<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2022.3779","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T15:32:18Z","timestamp":1664465538000},"page":"1076","source":"Crossref","is-referenced-by-count":9,"title":["Doxycycline vs Placebo at 12 Weeks in Patients With Mild Thyroid-Associated Ophthalmopathy"],"prefix":"10.1001","volume":"140","author":[{"given":"Yuan","family":"Pan","sequence":"first","affiliation":[{"name":"Department of Ocular Immunology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Xi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ocular Immunology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Ocular Immunology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao-Li","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Ocular Immunology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"},{"name":"C-MER Dennis Lam Eye Hospital, Shenzhen, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-Ming","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Ocular Immunology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"},{"name":"Department of Ophthalmology, The Third Affiliated Hospital of Soochow University, Changzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Liang","family":"Xu","sequence":"additional","affiliation":[{"name":"Eye Center of Xiangya Hospital, Central South University, Changsha, China"},{"name":"Department of Ophthalmology, Xiangya Changde Hospital, Changde, China"},{"name":"Hunan Key Laboratory of Ophthalmology, Changsha, China"},{"name":"National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian-Qun","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Ninth People\u2019s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking Union Medical College Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Fujian Provincial Hospital, Fuzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-Ming","family":"Ai","sequence":"additional","affiliation":[{"name":"Department of Ocular Immunology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Tan","sequence":"additional","affiliation":[{"name":"Eye Center of Xiangya Hospital, Central South University, Changsha, China"},{"name":"Hunan Key Laboratory of Ophthalmology, Changsha, China"},{"name":"National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Fang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Ninth People\u2019s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Dong","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking Union Medical College Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Ying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Fujian Provincial Hospital, Fuzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Xu","sequence":"additional","affiliation":[{"name":"Eye Center of Xiangya Hospital, Central South University, Changsha, China"},{"name":"Hunan Key Laboratory of Ophthalmology, Changsha, China"},{"name":"National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sha","family":"Wang","sequence":"additional","affiliation":[{"name":"Eye Center of Xiangya Hospital, Central South University, Changsha, China"},{"name":"Hunan Key Laboratory of Ophthalmology, Changsha, China"},{"name":"National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Jie","family":"Ma","sequence":"additional","affiliation":[{"name":"Eye Center of Xiangya Hospital, Central South University, Changsha, China"},{"name":"Hunan Key Laboratory of Ophthalmology, Changsha, China"},{"name":"National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China"},{"name":"Department of Ophthalmology, Huzhou Central Hospital, Huzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Ninth People\u2019s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin-Yang","family":"Gan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking Union Medical College Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Tao","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking Union Medical College Hospital, Beijing, China"},{"name":"Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Fujian Provincial Hospital, Fuzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Yan","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Ocular Immunology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxing","family":"Guo","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"Dana Center of Preventive Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Pan-Doh","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuo-Ting","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Ocular Immunology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Ocular Immunology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Xun","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Ocular Immunology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Wen","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Ocular Immunology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuo-Yi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ocular Immunology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Ocular Immunology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"10","key":"eoi220058r1","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1056\/NEJMcp0806317","article-title":"Clinical practice. Graves\u2019 ophthalmopathy.","volume":"360","author":"Bartalena","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"eoi220058r2","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.beem.2011.09.004","article-title":"Prevention of Graves\u2019 ophthalmopathy.","volume":"26","author":"Bartalena","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"8","key":"eoi220058r3","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.4103\/ijo.IJO_2183_19","article-title":"Assessing the quality of life in Indian Graves\u2019 orbitopathy patients and validation of Hindi version of GO-QOL questionnaire.","volume":"68","author":"Delampady","year":"2020","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"eoi220058r4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1080\/08820538.2021.1937662","article-title":"Evaluation of meibomian gland loss and ocular surface changes in patients with mild and moderate-to-severe Graves\u2019 ophthalmopathy.","volume":"37","author":"Yilmaz Tugan","year":"2022","journal-title":"Semin Ophthalmol"},{"issue":"7","key":"eoi220058r5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1136\/bjo.82.7.773","article-title":"Development of a disease specific quality of life questionnaire for patients with Graves\u2019 ophthalmopathy: the GO-QOL.","volume":"82","author":"Terwee","year":"1998","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"eoi220058r6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1365-2265.1995.tb02597.x","article-title":"Natural history of thyroid associated ophthalmopathy.","volume":"42","author":"Perros","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"eoi220058r7","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy.","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"eoi220058r8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1089\/thy.2007.0315","article-title":"Consensus statement of the European group on Graves\u2019 orbitopathy (EUGOGO) on management of Graves\u2019 orbitopathy.","volume":"18","author":"Bartalena","year":"2008","journal-title":"Thyroid"},{"issue":"1","key":"eoi220058r9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1210\/jcem-73-1-213","article-title":"Effect of selenium supplementation in hypothyroid subjects of an iodine and selenium deficient area: the possible danger of indiscriminate supplementation of iodine-deficient subjects with selenium.","volume":"73","author":"Contempre","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"eoi220058r10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1530\/EJE-15-0069","article-title":"Does selenium supplementation affect thyroid function? results from a randomized, controlled, double-blinded trial in a Danish population.","volume":"172","author":"Winther","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"eoi220058r11","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s12640-019-00015-z","article-title":"The neuroprotective effect of doxycycline on neurodegenerative diseases.","volume":"35","author":"Santa-Cec\u00edlia","year":"2019","journal-title":"Neurotox Res"},{"issue":"2","key":"eoi220058r12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10787-011-0077-5","article-title":"Anti-inflammatory properties of doxycycline and minocycline in experimental models: an in vivo and in vitro comparative study.","volume":"19","author":"Leite","year":"2011","journal-title":"Inflammopharmacology"},{"issue":"2","key":"eoi220058r13","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/(ISSN)1529-0131","article-title":"Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone.","volume":"54","author":"O\u2019Dell","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"11","key":"eoi220058r14","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1111\/jdv.2017.31.issue-11","article-title":"Doxycycline as an anti-inflammatory agent: updates in dermatology.","volume":"31","author":"Henehan","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10079","key":"eoi220058r15","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/S0140-6736(17)30560-3","article-title":"Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial.","volume":"389","author":"Williams","year":"2017","journal-title":"Lancet"},{"issue":"11","key":"eoi220058r16","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1136\/bjophthalmol-2015-306733","article-title":"PREGO (presentation of Graves\u2019 orbitopathy) study: changes in referral patterns to European Group On Graves\u2019 Orbitopathy (EUGOGO) centres over the period from 2000 to 2012.","volume":"99","author":"Perros","year":"2015","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"eoi220058r17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1530\/eje.1.02230","article-title":"Clinical assessment of patients with Graves\u2019 orbitopathy: the European Group on Graves\u2019 Orbitopathy recommendations to generalists, specialists and clinical researchers.","volume":"155","author":"Wiersinga","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"eoi220058r18","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1046\/j.1365-2265.2001.01241.x","article-title":"Interpretation and validity of changes in scores on the Graves\u2019 ophthalmopathy quality of life questionnaire (GO-QOL) after different treatments.","volume":"54","author":"Terwee","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"eoi220058r19","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the Ocular Surface Disease Index.","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"eoi220058r20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/cen.2005.63.issue-4","article-title":"Psychosocial morbidity of Graves\u2019 orbitopathy.","volume":"63","author":"Kahaly","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"eoi220058r21","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ajo.2011.02.018","article-title":"Quality of life in a german graves orbitopathy population.","volume":"152","author":"Ponto","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"20","key":"eoi220058r22","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1056\/NEJMoa1012985","article-title":"Selenium and the course of mild Graves\u2019 orbitopathy.","volume":"364","author":"Marcocci","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"eoi220058r23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1046\/j.1365-2265.2001.01349.x","article-title":"Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment.","volume":"55","author":"Dickinson","year":"2001","journal-title":"Clin Endocrinol"},{"key":"eoi220058r24","first-page":"113","article-title":"Ocular changes in Graves\u2019 disease. a long-term follow-up study.","volume":"29","author":"Hales","year":"1960","journal-title":"Q J Med"},{"issue":"1","key":"eoi220058r25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1089\/thy.2013.0240","article-title":"Spontaneous improvement of untreated mild Graves\u2019 ophthalmopathy: Rundle\u2019s curve revisited.","volume":"24","author":"Menconi","year":"2014","journal-title":"Thyroid"},{"issue":"5","key":"eoi220058r26","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1089\/thy.1998.8.423","article-title":"Natural history of thyroid eye disease.","volume":"8","author":"Perros","year":"1998","journal-title":"Thyroid"},{"issue":"3","key":"eoi220058r27","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1001\/archophthalmol.2011.29","article-title":"Rundle and his curve.","volume":"129","author":"Bartley","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"eoi220058r28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.615993","article-title":"Epidemiology, natural history, risk factors, and prevention of Graves\u2019 orbitopathy.","volume":"11","author":"Bartalena","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"eoi220058r29","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1210\/jc.2015-4294","article-title":"Risk factors for Graves\u2019 orbitopathy; the Australian Thyroid-Associated Orbitopathy Research (ATOR) study.","volume":"101","author":"Khong","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"eoi220058r30","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1365-2265.1992.tb01445.x","article-title":"Graves\u2019 ophthalmopathy in relation to cigarette smoking and ethnic origin.","volume":"36","author":"Tellez","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"eoi220058r31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0176064","article-title":"Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases.","volume":"12","author":"Li","year":"2017","journal-title":"PLoS One"},{"issue":"12","key":"eoi220058r32","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1089\/thy.2008.0044","article-title":"Prevalence, risk factors, and clinical features of thyroid-associated ophthalmopathy in multiethnic Malaysian patients with Graves\u2019 disease.","volume":"18","author":"Lim","year":"2008","journal-title":"Thyroid"},{"issue":"3","key":"eoi220058r33","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1902\/jop.2004.75.3.453","article-title":"Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug.","volume":"75","author":"Lee","year":"2004","journal-title":"J Periodontol"},{"issue":"2","key":"eoi220058r34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41574-019-0305-4","article-title":"New insights into the pathogenesis and nonsurgical management of Graves orbitopathy.","volume":"16","author":"Taylor","year":"2020","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"eoi220058r35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.17219\/acem\/68991","article-title":"Elevated serum concentrations of metalloproteinases (MMP-2, MMP-9) and their inhibitors (TIMP-1, TIMP-2) in patients with Graves\u2019 orbitopathy.","volume":"27","author":"Kapelko-Slowik","year":"2018","journal-title":"Adv Clin Exp Med"},{"issue":"2","key":"eoi220058r36","first-page":"105","article-title":"Serum gelatinases (MMP-2 and MMP-9) and VCAM-1 as a guideline in a therapeutic approach in Graves\u2019 ophthalmopathy.","volume":"58","author":"Mysliwiec","year":"2007","journal-title":"Endokrynol Pol"},{"issue":"5","key":"eoi220058r37","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140853","article-title":"Tetracyclines improve experimental lymphatic filariasis pathology by disrupting interleukin-4 receptor-mediated lymphangiogenesis.","volume":"131","author":"Furlong-Silva","year":"2021","journal-title":"J Clin Invest"},{"issue":"9","key":"eoi220058r38","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1902\/jop.2008.080051","article-title":"Doxycycline reduces lipopolysaccharide-induced inflammatory mediator secretion in macrophage and ex vivo human whole blood models.","volume":"79","author":"Cazalis","year":"2008","journal-title":"J Periodontol"},{"issue":"1","key":"eoi220058r39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1503\/jpn.090061","article-title":"Doxycycline inhibits proinflammatory cytokines but not acute cerebral cytogenesis after hypoxia-ischemia in neonatal rats.","volume":"35","author":"Jantzie","year":"2010","journal-title":"J Psychiatry Neurosci"},{"issue":"3","key":"eoi220058r40","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s10753-020-01188-y","article-title":"Immunomodulatory effect of doxycycline ameliorates systemic and pulmonary inflammation in a murine polymicrobial sepsis model.","volume":"43","author":"Patel","year":"2020","journal-title":"Inflammation"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2796841\/jamaophthalmology_pan_2022_oi_220058_1668089440.69515.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T16:03:14Z","timestamp":1668700994000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2796841"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2022.3779","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,1]]}}}